I joined ScHARR, University of Sheffield in 1999 as a systematic reviewer and have undertaken literature reviews on various topics including: newborn screening for inborn errors of metabolism, statins for the prevention of cardiovascular events, ezetimibe for the treatment of hypercholesterolaemia and diagnostic management strategies for adults and children with minor head injury.
In 2011, I became the Deputy Director of the ScHARR Technology Assessment Group (ScHARR-TAG). ScHARR-TAG undertakes reviews of the clinical and cost effectiveness of health care interventions for the National Institute for Health Research (NIHR). Health Technology Assessment Programme on behalf of a range of policy makers, including the National Institute for Health and Clinical Excellence (NICE)
For further details see: